expert roundtables

Unmet Treatment Needs Span the Natural History of Rheumatoid Arthritis
Rheumatology

Unmet Treatment Needs Span the Natural History of Rheumatoid Arthritis

expert roundtables
By John R. P. Tesser, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO; Vibeke Strand, MD, MACR, FACP
Immune Dysfunction and Infection Risk in Chronic Lymphocytic Leukemia
Oncology

Immune Dysfunction and Infection Risk in Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Identifying the Role of Disease-Modifying Drugs in the Treatment of Patients With Multiple Sclerosis
Neurology

Identifying the Role of Disease-Modifying Drugs in the Treatment of Patients With Multiple Sclerosis

expert roundtables
By David A. Hafler, MD; Dean Wingerchuk, MD, FRCP(C), MSc; Staley Brod, MD
Treatment Goals and Strategies for Patients With Primary Progressive Multiple Sclerosis
Neurology

Treatment Goals and Strategies for Patients With Primary Progressive Multiple Sclerosis

expert roundtables
By Aaron Miller, MD; Patricia K. Coyle, MD, FAAN, FANA; Scott Newsome, DO, MSCS, FAAN
Novel Therapeutic Combinations for Chronic Lymphocytic Leukemia
Oncology

Novel Therapeutic Combinations for Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Load More